For Penn
For Industry
PCI Ventures
Innovation at Penn
Info
Available Technologies
Browse Penn-owned technologies available for licensing.
HOME
SEARCH
RSS FEED
Search Results - pulmonary
3
Results
Sort By:
Published Date
Title
ID
Descending
Ascending
Rapid and ultrasensitive SARS-CoV-2 antigen detection for acute COVID-19 screening in community settings
A portable point-of-care device for rapid and sensitive detection of acute SARS-CoV-2 infections. Problem: The COVID-19 pandemic has infected over 40 million people worldwide as of mid-October 2020, causing more than 1 million deaths. Up to 50-80% of transmissions occur from asymptomatic patients. Current tests can have a turnaround time of hours...
Published:
11/11/2020
Inventor(s):
Ping Wang
Keywords(s):
COVID-19
,
Immunology
,
Infectious Disease
,
Microfluidics
,
Pulmonary
Category(s):
Diagnostics
Targeted drug delivery using red-blood cells for transport
Platform technology for targeted drug delivery using red blood cells for transport. Problem: Drug delivery can often result in up to 99% of the drug being delivered to off-target organs. This can lead to side-effects and toxicities. Current methods that bind drugs to red-blood cells for transport can require modifying the structure of the red blood...
Published:
6/23/2020
Inventor(s):
Laura Ferguson
,
Elizabeth Hood
,
Carlos Villa
,
Jacob Brenner
,
Vladimir Muzykantov
Keywords(s):
Cardiovascular
,
COVID-19
,
Drug Delivery
,
Nanotechnology
,
Pulmonary
Category(s):
Therapeutics & Vaccines
Inhibiting diacylglycerol kinase (DGK) for asthma treatment
ediators from T helper 2 (Th2) cells and non-immune effectors, such as smooth muscle shortening, which causes airway obstruction during an asthmatic attack. Treatments targeting inflammatory mediators do not always lead to a reduction in airway hyper-responsiveness. Thus, alternate ways to target both inflammatory and non-immune effectors are needed...
Published:
2/26/2019
Inventor(s):
Taku Kambayashi
Keywords(s):
Pulmonary
Category(s):
Therapeutics & Vaccines